The FDA approved an Alzheimer's Drug made by the biopharmaceutical company Biogen (BIIB), which sent shares of the stock up nearly 40 percent on Monday, June 7, 2021. Shares of another pharma company Eli Lilly (LLY) also shot up, gaining more than ten percent as the company also has an Alzheimer's drug candidate in its pipeline. Tom Essaye joins Ben to talk about the news making moves within the pharma sector as well as other noteworthy stocks.
Trading 360
23 Feb 2022
Market On Close
05 Apr 2022
Trading 360
18 Apr 2022
Market On Close
23 Feb 2022
Morning Trade Live
18 Mar 2022
Morning Trade Live
23 Mar 2022